How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Palliative Care and Hospice Market
- By Service Type: Inpatient Hospice Care, Home Hospice Care, Outpatient Palliative Care, Nursing Home Hospice Care, Telehealth Palliative Care
- By Care Setting: Hospitals, Hospice Facilities, Home Care, Long-term Care Facilities, Specialized Palliative Care Clinics
- By Patient Age Group: Adult Palliative Care, Pediatric Palliative Care, Geriatric Palliative Care
- By Disease Indication: Cancer, Cardiovascular Diseases, Neurological Disorders, Chronic Respiratory Diseases, Renal Failure
- By Provider Type: Hospice Organizations, Home Healthcare Agencies, Hospitals, Specialized Palliative Care Providers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Inpatient Hospice Care leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Palliative Care and Hospice Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
Care Setting 5
Patient Age Group 3
Disease Indication 5
Provider Type 4
Companies profiled
Kindred Healthcare (now part of LifePoint Health)
Encompass Health Corporation
Amedisys Inc.
LHC Group Inc.
VITAS Healthcare
Brookdale Senior Living
Genesis HealthCare
Chemed Corporation (VITAS Healthcare)
Addus HomeCare Corporation
Almost Family Inc.
Sage Hospice
Seasons Hospice & Palliative Care
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Kindred Healthcare (now part of LifePoint Health)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Encompass Health Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Amedisys Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →LHC Group Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →VITAS Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Brookdale Senior Living
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Genesis HealthCare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Chemed Corporation (VITAS Healthcare)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Addus HomeCare Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Almost Family Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Sage Hospice
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Seasons Hospice & Palliative Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Compassus
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →AccentCare Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Curo Health Services
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,287M by 2033 · 5.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Inpatient Hospice Care45.5
- Home Hospice Care11.0
- Outpatient Palliative Care11.6
- Nursing Home Hospice Care15.2
- Telehealth Palliative Care16.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$280.0M → $417.1M · 5.1%
Europe$195.2M → $263.1M · 3.8%
Asia Pacific$178.2M → $247.3M · 4.2%
Latin America$110.3M → $152.1M · 4.1%
Middle East and Africa$84.9M → $139.9M · 6.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.302026
5.312027
5.332028
5.332029
5.352030
5.372031
5.372032
5.392033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Kindred Healthcare (now part of LifePoint Health)14.3
- Encompass Health Corporation22.7
- Amedisys Inc.6.8
- LHC Group Inc.8.0
- VITAS Healthcare12.6
- Brookdale Senior Living7.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type15.2%
Care Setting18.2%
Patient Age Group25.0%
Disease Indication16.5%
Provider Type25.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.2
- Europe21.6
- Asia Pacific20.3
- Latin America12.5
- Middle East and Africa11.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Kindred Healthcare (now part of LifePoint Health) | 76 | 74 | 88 | 98 | 82 | 80 | 83 |
| Encompass Health Corporation | 89 | 89 | 84 | 72 | 85 | 77 | 83 |
| Amedisys Inc. | 78 | 69 | 67 | 77 | 86 | 80 | 76 |
| LHC Group Inc. | 59 | 62 | 66 | 82 | 74 | 61 | 67 |
| VITAS Healthcare | 74 | 71 | 69 | 55 | 77 | 53 | 67 |
| Brookdale Senior Living | 55 | 49 | 62 | 52 | 65 | 64 | 58 |
| Genesis HealthCare | 62 | 61 | 47 | 54 | 46 | 53 | 54 |
| Chemed Corporation (VITAS Healthcare) | 57 | 48 | 43 | 58 | 40 | 55 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Kindred Healthcare (now part of LifePoint Health)
- Encompass Health Corporation
- Amedisys Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Kindred Healthcare (now part of LifePoint Health) | ◐ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Encompass Health Corporation | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Amedisys Inc. | ◐ | − | ◐ | ◐ | ◐ | ◐ |
| LHC Group Inc. | − | ✓ | ✓ | ✓ | ✓ | − |
| VITAS Healthcare | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Brookdale Senior Living | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Genesis HealthCare | ◐ | − | ◐ | ◐ | − | − |
| Chemed Corporation (VITAS Healthcare) | ◐ | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Kindred Healthcare (now part of LifePoint Health)83
2Encompass Health Corporation83
3Amedisys Inc.76
4LHC Group Inc.67
5VITAS Healthcare67
6Brookdale Senior Living58
7Genesis HealthCare54
8Chemed Corporation (VITAS Healthcare)50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Kindred Healthcare (now part of LifePoint Health)Encompass Health Corporation
Challenger3
Strong scale, closing on the leaders.
Amedisys Inc.LHC Group Inc.VITAS Healthcare
Contender1
Focused players with pockets of strength.
Brookdale Senior Living
Niche2
Specialists in a single segment or region.
Genesis HealthCareChemed Corporation (VITAS Healthcare)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Palliative Care and Hospice Market — a $91M beachhead inside a $1.46B market.
Beachhead (SOM)$91Mobtainable near-term
Serviceable (SAM)$595Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Inpatient Hospice Care
Best fit — highest urgency & budget in Service Type.
Economic buyer78 fit
Home Hospice Care
Strong fit — clear ROI and a fast path to value.
End user68 fit
Outpatient Palliative Care
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Care Setting & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Patient Age Group
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel27%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Palliative Care and Hospice Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation11%
Closed-won8%
$9.9KCAC
$40KLTV
4.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Palliative Care and Hospice Market is a resilient opportunity — $2.93B by 2033, compounding at 4.0%.
TAM · 2025$2.13Btoday
TAM · 2033$2.93Bforecast
CAGR4.0%2027–2033
Cumulative$22.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.93BTotal addressable market
SAM$1.05BServiceable available market
SOM$230MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.0% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.93BLarge & growingTAM by 2033 at 4.0% CAGR
$1.05BServiceable nowreachable with today’s model
$230MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.28BBear2.6% CAGR
$2.93BBase4.0% CAGR
$3.75BBull5.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Care Setting optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Palliative Care and Hospice Market — a $7.62B market by 2033. Plan: grow share from 6.7% to 12.8%.
Market size · 2033$7.62Btotal addressable
Market CAGR5.1%2027–2033
Target share12.8%from 6.7% today
Revenue ambition$976Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.7% | 12.8% | Ahead |
| Revenue | $492M | $976M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 36.8% | 45.1% | At risk |
| Customer retention | 90.7% | 92.1% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Care Setting capability
A defensible second engine — invest in Care Setting to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Care Setting
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $143M capacity & capability investment
- Greenlight bolt-on M&A in Care Setting
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Palliative Care and Hospice Market conversation — a $5.45B market you can size, segment and defend in minutes.
Market size · 2033$5.45Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,315+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 3 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Kindred Healthcare (now part of LifePoint Health)Encompass Health CorporationAmedisys Inc.LHC Group Inc.VITAS HealthcareBrookdale Senior LivingGenesis HealthCareChemed Corporation (VITAS Healthcare)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Palliative Care and Hospice Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Palliative Care and Hospice Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Palladium-103 Seeds Source Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportPaliperidone Extended Release Tablets Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportPaliperidone API Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportPalbociclib Drug Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportPalbociclib Capsules Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportPalbociclib API Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportPalatal Expander Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportPain Treatment Medication Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportPain Treatment Drug Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportPain Therapy Device Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportPain Therapeutic Injection Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportPain Testing Machine Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.